NCT06695533

Brief Summary

The goals of this study are to:

  • Complete the workbook during their waiting time in the clinic or at home.
  • Engage in word games designed to teach diabetes management vocabulary and concepts.
  • Attend follow-up sessions to assess changes in self-efficacy and glycemic control.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable diabetes

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 16, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 19, 2024

Completed
9 months until next milestone

Study Start

First participant enrolled

August 21, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 12, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 12, 2026

Completed
Last Updated

April 29, 2026

Status Verified

February 1, 2026

Enrollment Period

6 months

First QC Date

November 16, 2024

Last Update Submit

April 24, 2026

Conditions

Keywords

Diabetes self-managementPatient educationGlycemic control

Outcome Measures

Primary Outcomes (4)

  • Diabetes self-efficacy score (Diabetes management self-efficacy (DMSE)

    Measures the confidence of patients with diabetes regarding diet, exercise and medical treatment)

    Pre test, post test (3months)

  • Knowledge of American Diabetes Association (ADA) diabetes plate method

    The ADA diabetes plate method is a meal planning tool that divides a plate into three sections: half for non-starchy vegetables, one-quarter for lean protein, and one-quarter for whole grains or starchy foods. It helps individuals with diabetes control portions and manage carbohydrate intake for better blood glucose control.

    Pre test, post test (3months)

  • Acceptability of Intervention Measure (AIM)

    The Acceptability of Intervention Measure (AIM) is a tool used to assess how acceptable an intervention is to participants. The AIM is a 4-item instrument that uses a 5-point Likert scale

    Pre test, post test (3months)

  • Feasibility of Intervention Measure (FIM)

    The Feasibility of Intervention Measure (FIM) is a tool used to assess the perceived feasibility of an intervention. The FIM is a 4-item instrument that uses a 5-point Likert scale.

    Pre test, post test (3months)

Secondary Outcomes (3)

  • Change in Hemoglobin A1c

    Pre test, post test (3months)

  • Change in Weight

    Pre test, post test (3months)

  • Change in Blood Pressure

    Pre test, post test (3months)

Study Arms (1)

Diabetes self management

EXPERIMENTAL

Eligible participants will utilize the workbook for a span of 3 months

Behavioral: Diabetes self management workbook

Interventions

The diabetes self-management workbook section used in this pilot study will focus on diet management, specifically carbohydrates, following ADA guidelines. It will include exercises based on the ADA diabetes plate method, aimed at helping subjects understand meal planning, food categories, portion sizes, goal setting, and the impact of foods on blood glucose levels. Activities will include word searches, crosswords, and goal-setting exercises. Subjects will begin the first section during a clinic visit. They can complete the workbook at home over three months, with input from subjects and Certified Diabetes Care and Education Specialists to refine the content.

Diabetes self management

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients: adult with diabetes and patient at the Midtown Clinic
  • Caregivers: partner, or caregiver of a patient with diabetes
  • Providers: Physician Assistant (PA), Nurse Practitioner (NP), or MD who cares for patients with diabetes
  • Diabetes educators: diabetes educator

You may not qualify if:

  • Cannot speak/read English
  • Unwilling to participate in group discussion
  • Pregnancy
  • Having type 2 diabetes which is not insulin dependent since insulin management adds another level of diabetes self-management that would confound self-efficacy scores.
  • Having a hemoglobin a1c less than 10% based on their last 3 hemoglobin a1c readings within the 2 years before the recruitment phase of the study. The ADA recommends the initiation of insulin therapy for individuals with a hemoglobin a1c above 10%, therefore the study will focus on an intervention for diabetes before insulin is likely to be part of the management plan.
  • Not having any conditions that could interfere with the accuracy of a hemoglobin a1c result: anemia, hemoglobinopathy, end-stage renal disease, chronic liver disease.
  • The ability to read a passage set at a fifth-grade literacy, a score of at least 3 on the Mini-Cog test scale which would represent a lower likelihood of dementia, and the ability to drive to medical visits.
  • Subjects will represent a diversity of age, educational level, and socioeconomic status (will use type of medical insurance as a proxy)
  • Cannot speak/read English
  • Unwilling to return for a follow-up visit in 3 months
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emory Midtown Clinic

Atlanta, Georgia, 30329, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Catherine Park, MD

    Emory University

    PRINCIPAL INVESTIGATOR
  • Saria Hassan, MD

    Emory University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: The workbook will be designed with the help of 5 focus group discussions. Five focus groups will include participants from one of the following categories: patients, caregivers, providers, and diabetes educators. Each focus group will have 6-10 participants.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 16, 2024

First Posted

November 19, 2024

Study Start

August 21, 2025

Primary Completion

February 12, 2026

Study Completion

February 12, 2026

Last Updated

April 29, 2026

Record last verified: 2026-02

Locations